The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.

Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate ...

Guidance was raised again, with operational sales growth midpoint moving to 5.1% (previous: 4.8%) and reported sales growth midpoint at 5.7% (previous: 5.4%), reflecting increased confidence in both ...

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.

Gavel brings highly relevant CAR T experience from Legend Biotech where he led the launch and commercialization of CARVYKTI® from 2018 until 2025 - ...

Johnson & Johnson (NYSE:JNJ) is included among the 12 Reliable Dividend Stocks for Maximum Income. Johnson & Johnson ...

Hologic HOLX continues to experience strong momentum across its GYN Surgical portfolio, underscoring the increasing global focus on women’s health. The company’s investments in commercial and market ...

Charleston County leaders are debating new incentives to secure the expansion of a global manufacturing company in the ...

NEW BRUNSWICK, N.J. (AP) — NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Tuesday reported third-quarter earnings of $5.15 billion. On a per-share basis, the New Brunswick, New Jersey-based ...